CIVIERO, LAURA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 2.432
EU - Europa 165
AS - Asia 153
Totale 2.750
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.430
CN - Cina 151
IT - Italia 69
FI - Finlandia 35
SE - Svezia 22
DE - Germania 12
GB - Regno Unito 12
FR - Francia 4
IE - Irlanda 4
NL - Olanda 3
UA - Ucraina 3
IN - India 2
CA - Canada 1
CH - Svizzera 1
MX - Messico 1
Totale 2.750
Salva come PNG Salva come JPEG
Città #
Fairfield 449
Chandler 260
Woodbridge 231
Ashburn 227
Ann Arbor 187
Houston 184
Seattle 162
Cambridge 149
Wilmington 136
San Diego 46
Beijing 36
Padova 36
Princeton 35
Des Moines 34
Medford 33
Guangzhou 23
Nanjing 23
Helsinki 19
Roxbury 16
Boardman 12
Shanghai 8
Jacksonville 7
Shenyang 6
Changsha 5
New York 5
Phoenix 4
San Francisco 4
Tianjin 4
Dublin 3
Falls Church 3
Hefei 3
Indiana 3
Nanchang 3
Norwalk 3
Paris 3
Rome 3
Zhengzhou 3
Barneveld 2
Borås 2
Chiampo 2
Chongqing 2
Curtarolo 2
Hangzhou 2
Hebei 2
Jinan 2
Kharkiv 2
Kilburn 2
Kunming 2
Milan 2
Montano Lucino 2
Ogden 2
Redwood City 2
Seregno 2
Tappahannock 2
Venice 2
Washington 2
Bologna 1
Brentford 1
Buffalo 1
Camden 1
Chengdu 1
Chiswick 1
Dongguan 1
Edinburgh 1
Haikou 1
Jian 1
Jiaxing 1
Lanzhou 1
Leawood 1
London 1
Los Angeles 1
Monmouth Junction 1
Monza 1
Nanping 1
Ningbo 1
Olbia 1
Portland 1
Portlaoise 1
Prescot 1
Quzhou 1
Southwark 1
Toronto 1
Verona 1
Wandsworth 1
Zurich 1
Totale 2.435
Salva come PNG Salva come JPEG
Nome #
LRRK2 phosphorylates pre-synaptic N-ethylmaleimide sensitive fusion (NSF) protein enhancing its ATPase activity and SNARE complex disassembling rate 165
The role of LRRK2 in cytoskeletal dynamics 139
Leucine-rich repeat kinase 2 and alpha-synuclein: intersecting pathways in the pathogenesis of Parkinson's disease? 116
Biochemical Characterization of Highly Purified Leucine-Rich Repeat Kinases 1 and 2 Demonstrates Formation of Homodimers 105
Pharmacological LRRK2 kinase inhibition induces LRRK2 protein destabilization and proteasomal degradation 104
Glial phagocytic clearance in Parkinson’s disease 103
Unbiased screen for interactors of leucine-rich repeat kinase 2 supports a common pathway for sporadic and familial Parkinson disease 102
Ceramides in Parkinson's Disease: From Recent Evidence to New Hypotheses 101
Analysis of the Catecholaminergic Phenotype in Human SH-SY5Y and BE(2)-M17 Neuroblastoma Cell Lines upon Differentiation 96
Differential protein-protein interactions of LRRK1 and LRRK2 indicate roles in distinct cellular signaling pathways. 96
Leucine-rich repeat kinase 2 interacts with p21-activated kinase 6 to control neurite complexity in mammalian brain 95
Human leucine-rich repeat kinase 1 and 2: intersecting or unrelated functions? 94
GTP binding and intramolecular regulation by the ROC domain of Death Associated Protein Kinase 1. 93
Parkinson's disease and immune system: is the culprit LRRKing in the periphery? 92
GTP binding controls complex formation by the human ROCO protein MASL1 91
LRRK2 deficiency impacts ceramide metabolism in brain 90
Genetic, structural, and molecular insights into the function of RAS of complex proteins domains 83
GTPase activity regulates kinase activity and cellular phenotypes of Parkinson's disease-associated LRRK2 83
Divergent Effects of G2019S and R1441C LRRK2 Mutations on LRRK2 and Rab10 Phosphorylations in Mouse Tissues 79
PAK6 Phosphorylates 14-3-3γ to Regulate Steady State Phosphorylation of LRRK2 72
Molecular insights and functional implication of LRRK2 dimerization 69
BEL -trefoil: A novel lectin with antineoplastic properties in king bolete (Boletus edulis) mushrooms 69
New tools for membrane protein research 69
Neuronal autophagy, α-synuclein clearance, and LRRK2 regulation: A lost equilibrium in parkinsonian brain 68
Genetic, Structural, and Molecular Insights into the Function of Ras of Complex Proteins Domains 67
The LRRK2 variant E193K prevents mitochondrial fission upon MPP+ treatment by altering LRRK2 binding to DRP1 60
PAKs in the brain: Function and dysfunction 59
Co-occurring WARS2 and CHRNA6 mutations in a child with a severe form of infantile parkinsonism 58
RAB8, RAB10 and RILPL1 contribute to both LRRK2 kinase-mediated centrosomal cohesion and ciliogenesis deficits 57
Parkinson’s Disease–Associated LRRK2 Interferes with Astrocyte-Mediated Alpha-Synuclein Clearance 55
Glutamate-induced excitotoxicity in Parkinson's disease: The role of glial cells 35
The Roc domain of LRRK2 as a hub for protein-protein interactions: a focus on PAK6 and its impact on RAB phosphorylation 29
Microglia-Derived Small Extracellular Vesicles Reduce Glioma Growth by Modifying Tumor Cell Metabolism and Enhancing Glutamate Clearance through miR-124 25
Cytosolic sequestration of spatacsin by Protein Kinase A and 14-3-3 proteins 20
Pathways to Parkinson's disease: a spotlight on 14-3-3 proteins 17
LRRK2 kinase activity regulates GCase level and enzymatic activity differently depending on cell type in Parkinson's disease 16
Trafficking of the glutamate transporter is impaired in LRRK2-related Parkinson's disease 14
Site‐Specific Ubiquitination of Tau Amyloids Promoted by the E3 Ligase CHIP 5
Investigation of microglial diversity in a LRRK2 G2019S mouse model of Parkinson's disease. 3
LRRK2 regulates synaptic function through BDNF signaling and actin cytoskeleton 2
Brain clearance of protein aggregates: a close-up on astrocytes. 1
Totale 2.797
Salva come PNG Salva come JPEG
Categoria #
all - tutte 10.665
article - articoli 10.354
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 311
Totale 21.330
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019188 0 0 0 0 0 0 0 0 0 0 109 79
2019/2020590 73 20 17 67 66 35 67 77 69 49 38 12
2020/2021517 18 20 15 31 133 11 6 42 74 76 79 12
2021/2022521 11 43 89 37 32 17 24 64 38 11 46 109
2022/2023454 78 65 15 76 44 46 2 42 58 4 17 7
2023/2024228 9 42 24 21 12 18 20 13 26 42 1 0
Totale 2.797